According to ai_9684xtpa analysis, BIO Protocol has raised $30.2 million through fundraising: two rounds of private placement, a total of 2.3 million US dollars, with a valuation of 35 million US dollars and 69 million US dollars respectively;
The three rounds of public offering (i.e. BIO Genesis auction) raised a total of 27.9 million US dollars, and the three rounds were valued at 85 million US dollars/142 million US dollars/219 million US dollars.
At present, BIO has launched Bybit and Bitget pre-market trading. According to the pre-market average price of 0.9659 dollars on the two platforms at 12.29 22:00, BIO FDV is about 3.20 billion dollars. Private investors: 13.60% of the total supply; Public investors: 20.00% of the total supply. Costs are as follows:
private placement
Before the seed round: the cost is about $0.01054, and the current floating profit is 91.62 times.
In the seed round: the cost is about $0.02078, and the current floating profit is 46.48 times.
public offering
· Round 1: The cost is about $0.0256, and the current floating profit is 37.73 times;
· Round 2: The cost is about $0.04277, and the current floating profit is 22.58 times;
Round 3: The cost is about $0.06596, and the current floating profit is 14.64 times.
Analysis: The maximum floating profit of BIO private equity participants has reached 92 times, and the minimum floating profit of public offerings is nearly 15 times
2024-12-30 04:41:26
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
分析：BIO私募参与者浮盈最高已达92倍，公募最低浮盈近15倍Next article：
数据：12月比特币矿工收入已达13.3亿美元，创今年五月以来新高
